查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1621148

2024 - 2032 年动物药品市场机会、成长动力、产业趋势分析与预测

Animal Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球动物药品市场规模达370亿美元，预计2024年至2032年复合年增长率为5.4%，到预测期结束时将超过450亿美元。主要驱动因素包括动物疾病盛行率上升、消费者对动物健康意识的提高以及越来越多地采用牲畜进行食品生产。兽药配方的进步也促进了市场成长，确保更好的功效和合规性。

包括抗感染药、杀寄生虫药和疫苗在内的药品占据市场主导地位，持续创新推动成长。 2023年，药物领域在动物药物市场中累积占58.8%的最大份额，并且在新配方的引入和联合疗法的使用增加的帮助下，预计将显着增长。人们对预防保健的认识不断提高，以及牲畜和伴侣动物疫苗接种计划的重要性，推动了对这些药物的需求。此外，生物技术和分子研究的进步有助于开发高效治疗方法。

到 2023 年，畜牧业占据了约 62.5% 的主导份额。用于预防疾病爆发和优化动物生产力的预防性和治疗性药物的使用推动了该细分市场的成长。此外，全球生产者和政府对农场动物健康的投资不断增加，预计将维持强劲的需求。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 370 亿美元
预测值 596 亿美元
复合年增长率 5.4%

2023 年，注射药物销售额达 166 亿美元，由于其起效快且易于剂量控制，作为首选给药途径越来越受到关注。它们通常用于伴侣动物和牲畜的疫苗接种、抗生素和激素治疗。配方和输送系统的创新提高了注射药物的稳定性和有效性，使其成为兽医实践中的重要工具。该领域的成长得益于动物保健意识的提高和进步。

到 2023 年，兽医医院将占据整体市场份额的 37.4%，并且在全面医疗服务和先进治疗的推动下，预计将继续保持领先的配销通路。宠物拥有量的激增和对牲畜福利的日益关注进一步支持了细分市场的成长。这些医院拥有熟练的兽医和先进的诊断设施，确保了药物的有效管理。综合医疗保健系统的趋势进一步加强了它们在市场中的作用。

在强大的基础设施和对动物保健的高度关注的推动下，北美仍然是最大的动物药品市场，到 2023 年价值将达到 140 亿美元。监管框架、先进的研究设施和对兽药的重大投资推动了该地区的成长。对伴侣动物和牲畜生产力提高解决方案的需求不断增加，进一步扩大了区域市场的扩张。

2023年，美国动物药品市场规模达127亿美元。兽医护理设施的不断升级和对动物健康研究的投资进一步凸显了美国市场的实力。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 宠物保险需求激增
      • 伴侣动物肥胖率上升
      • 加大政府对宠物照护的支持
      • 对网路兽药局的需求不断增长
    • 产业陷阱与挑战
      • 与动物药品相关的高成本
  • 成长潜力分析
  • 监管环境
  • 政策格局
  • 产品管道分析
  • 投资者概览
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2018 年 - 2032 年

  • 主要趋势
  • 药品
    • 抗寄生虫药
    • 消炎剂
    • 抗感染药
    • 其他药品
  • 疫苗
    • 改良活疫苗 (MLV)
    • 灭活灭活疫苗
    • 其他疫苗
  • 药用饲料添加剂
    • 抗生素
    • 维生素
    • 酵素
    • 抗氧化剂
    • 益生元和益生菌
    • 矿物质
    • 其他药用添加剂

第 6 章：市场估计与预测：按动物类型，2018 - 2032

  • 主要趋势
  • 畜牧动物
    • 家禽
    • 猪
    • 牛
    • 鱼
    • 其他家畜动物
  • 伴侣动物
    • 狗
    • 猫
    • 马匹
    • 其他伴侣动物

第 7 章：市场估计与预测：按管理途径，2018 年 - 2032 年

  • 主要趋势
  • 口服
  • 可注射
  • 专题
  • 其他给药途径

第 8 章：市场估计与预测：按配销通路，2018 年 - 2032 年

  • 主要趋势
  • 兽医院
  • 兽医诊所
  • 药局和药局
  • 电子商务

第 9 章：市场估计与预测：按地区，2018-2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 波兰
    • 荷兰
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 台湾
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 海湾合作委员会国家
    • 以色列

第 10 章：公司简介

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals Ltd
  • Durvet, Inc.
  • Elanco Animal Health
  • Merck & Co., Inc
  • Neogen Corporation, Inc
  • Virbac SA
  • Vetoquinol SA
  • Zoetis, Inc
简介目录
Product Code: 4445

The global animal drugs market reached USD 37 billion in 2023 and is projected to grow at a CAGR of 5.4% between 2024 and 2032, surpassing USD 45 billion by the end of the forecast period. Key drivers include the rising prevalence of animal diseases, increased consumer awareness regarding animal health, and the growing adoption of livestock animals for food production. Advancements in veterinary pharmaceutical formulations also boost market growth, ensuring better efficacy and compliance.

Drugs, including anti-infectives, parasiticides, and vaccines, dominate the market, with continuous innovation fueling growth. In 2023, the drugs segment accumulated the largest share of 58.8% in the animal drugs market and is expected to grow significantly, aided by the introduction of novel formulations and increased use of combination therapies. Rising awareness about preventive care and the importance of vaccination programs for livestock and companion animals drive the demand for these drugs. Moreover, advancements in biotechnology and molecular research contribute to the development of highly effective treatments.

The livestock animal segment captured a dominant share of around 62.5% in 2023. Increased demand for high-quality meat, milk, and related products has amplified the need for effective healthcare solutions for cattle, poultry, and swine. Prophylactic and therapeutic drug use to prevent disease outbreaks and optimize animal productivity drive this segment's growth. Additionally, rising investments in farm animal health by producers and governments globally are expected to sustain robust demand.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$37 Billion
Forecast Value$59.6 Billion
CAGR5.4%

Injectable drugs amassed USD 16.6 billion in 2023 and are gaining traction as a preferred route of administration due to their quick efficacy and ease of dosage control. They are commonly used for vaccinations, antibiotics, and hormonal treatments in both companion animals and livestock. Innovations in formulation and delivery systems have improved the stability and effectiveness of injectable drugs, making them a vital tool in veterinary practice. This segment's growth is bolstered by increasing awareness and advancements in animal healthcare.

Veterinary hospitals held 37.4% of the overall market share in 2023 and are poised to remain the leading distribution channel, driven by the availability of comprehensive healthcare services and advanced treatments. A surge in pet ownership and increased focus on livestock welfare further support segment growth. The presence of skilled veterinarians and advanced diagnostic facilities in these hospitals ensures the effective administration of drugs. The trend toward integrated healthcare systems further strengthens their role in the market.

North America remains the largest market for animal drugs, valued at USD 14 billion in 2023, driven by robust infrastructure and a high focus on animal healthcare. Regulatory frameworks, advanced research facilities, and significant investments in veterinary medicine fuel growth in this region. Increasing demand for companion animals and livestock productivity enhancement solutions further amplifies the regional market's expansion.

The U.S. animal drugs market size reached USD 12.7 billion in 2023. Factors such as increased pet ownership, high livestock production, and regulatory support for disease control are fueling demand. Continuous upgrades in veterinary care facilities and investments in animal health research further underscore the U.S. market's strength.

Table of Contents

Chapter 1. Methodology & Scope

  • 1.1. Market scope & definitions
  • 1.2. Research design
    • 1.2.1. Research approach
    • 1.2.2. Data collection methods
  • 1.3. Base estimates & calculations
    • 1.3.1. Base year calculation
    • 1.3.2. Key trends for market estimation
  • 1.4. Forecast model
  • 1.5. Primary research and validation
    • 1.5.1. Primary sources
    • 1.5.2. Data mining sources

Chapter 2. Executive Summary

  • 2.1. Industry 360° synopsis

Chapter 3. Industry Insights

  • 3.1. Industry ecosystem analysis
  • 3.2. Industry impact forces
    • 3.2.1. Growth drivers
      • 3.2.1.1. Surging demand for pet insurance policies
      • 3.2.1.2. Rising rate of obesity in companion animals
      • 3.2.1.3. Increasing government support for pet care
      • 3.2.1.4. Growing demand for online veterinary pharmacies
    • 3.2.2. Industry pitfalls & challenges
      • 3.2.2.1. High cost associated with animal drugs
  • 3.3. Growth potential analysis
  • 3.4. Regulatory landscape
  • 3.5. Policy landscape
  • 3.6. Product pipeline analysis
  • 3.7. Investor overview
  • 3.8. Gap analysis
  • 3.9. Porter's analysis
  • 3.10.PESTEL analysis

Chapter 4. Competitive Landscape, 2023

  • 4.1. Introduction
  • 4.2. Company matrix analysis
  • 4.3. Competitive analysis of major market players
  • 4.4. Competitive positioning matrix
  • 4.5. Strategy dashboard

Chapter 5. Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1. Key trends
  • 5.2. Drugs
    • 5.2.1. Antiparasitic
    • 5.2.2. Anti-inflammatory
    • 5.2.3. Anti-infectives
    • 5.2.4. Other drugs
  • 5.3. Vaccines
    • 5.3.1. Modified Live Vaccines (MLV)
    • 5.3.2. Killed inactivated vaccines
    • 5.3.3. Other vaccines
  • 5.4. Medicated feed additives
    • 5.4.1. Antibiotics
    • 5.4.2. Vitamins
    • 5.4.3. Enzymes
    • 5.4.4. Antioxidants
    • 5.4.5. Prebiotics and probiotics
    • 5.4.6. Minerals
    • 5.4.7. Other medicated additives

Chapter 6. Market Estimates and Forecast, By Animal Type, 2018 - 2032 ($ Mn)

  • 6.1. Key trends
  • 6.2. Livestock animals
    • 6.2.1. Poultry
    • 6.2.2. Swine
    • 6.2.3. Cattle
    • 6.2.4. Fish
    • 6.2.5. Other livestock animals
  • 6.3. Companion animals
    • 6.3.1. Dogs
    • 6.3.2. Cats
    • 6.3.3. Horses
    • 6.3.4. Other companion animals

Chapter 7. Market Estimates and Forecast, By Route of Administration, 2018 - 2032 ($ Mn)

  • 7.1. Key trends
  • 7.2. Oral
  • 7.3. Injectable
  • 7.4. Topical
  • 7.5. Other routes of administration

Chapter 8. Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

  • 8.1. Key trends
  • 8.2. Veterinary hospitals
  • 8.3. Veterinary clinics
  • 8.4. Pharmacy and drug stores
  • 8.5. e-commerce

Chapter 9. Market Estimates and Forecast, By Region, 2018- 2032 ($ Mn)

  • 9.1. Key trends
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. UK
    • 9.3.3. France
    • 9.3.4. Spain
    • 9.3.5. Italy
    • 9.3.6. Poland
    • 9.3.7. Netherlands
  • 9.4. Asia Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Australia
    • 9.4.5. South Korea
    • 9.4.6. Taiwan
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Argentina
  • 9.6. Middle East and Africa
    • 9.6.1. South Africa
    • 9.6.2. GCC Countries
    • 9.6.3. Israel

Chapter 10. Company Profiles

  • 10.1. Boehringer Ingelheim International GmbH
  • 10.2.Ceva Sante Animale
  • 10.3.Dechra Pharmaceuticals Ltd
  • 10.4.Durvet, Inc.
  • 10.5.Elanco Animal Health
  • 10.6.Merck & Co., Inc
  • 10.7.Neogen Corporation, Inc
  • 10.8.Virbac S.A.
  • 10.9.Vetoquinol SA
  • 10.10. Zoetis, Inc